BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9427070)

  • 1. Cutaneous T-cell lymphoma.
    Dalton JA; Yag-Howard C; Messina JL; Glass LF
    Int J Dermatol; 1997 Nov; 36(11):801-9. PubMed ID: 9427070
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous T-cell lymphoma (mycosis fungoides).
    Lorincz AL
    Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous T-cell lymphoma. Preface.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():V. PubMed ID: 18405179
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous malignancies: KA, CTCL, and KS.
    Vargo N
    Dermatol Nurs; 2006 Jun; 18(3):270, 277. PubMed ID: 16856684
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group].
    Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M;
    Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant lymphoma of the skin--especially cutaneous T-cell lymphoma].
    Nakajima H
    Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(13):1336-8. PubMed ID: 2079742
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous lymphomas and COVID-19: What is known so far?
    Elmasry MF; Youssef R; Elbendary A; Helmy K; Abdelkader HA
    Dermatol Ther; 2021 Jan; 34(1):e14463. PubMed ID: 33112053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Willemze R; Dreyling M;
    Ann Oncol; 2009 May; 20 Suppl 4():115-8. PubMed ID: 19454428
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignant lymphoma of the skin].
    Kerl H; Volkenandt M; Cerroni L
    Hautarzt; 1994 Jun; 45(6):421-43; quiz 441-2. PubMed ID: 8071078
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral T-cell lymphoma, not otherwise specified presenting with multiple tender cutaneous nodules and plaques.
    Gupta V; Seshadri D; Khaitan BK; Nath D; Mridha AR
    Indian J Dermatol Venereol Leprol; 2015; 81(3):313-5. PubMed ID: 25784225
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous Lymphoma in Korea: A Nationwide Retrospective Study.
    Lee HS; Suh KS; Lee DY; Cho KH; Oh SH; Kim SC; Lee SJ; Shin DH; Yoon TY; Won YH; Kim YC
    Acta Derm Venereol; 2016 May; 96(4):535-9. PubMed ID: 26560051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv30-iv40. PubMed ID: 29878045
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressive epidermotropic cutaneous CD8+ (Berti's) lymphoma.
    Webber NK; Harwood C; Goldsmith P; Cerio R; Wells P; Kazmi M; Russell-Jones MR; Morris S; Robson A
    Clin Exp Dermatol; 2010 Jun; 35(4):e210-2. PubMed ID: 20518920
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of cutaneous lymphomas.
    Breneman DL
    Compr Ther; 1996 Mar; 22(3):169-74. PubMed ID: 8706387
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cutaneous lymphoma at the Dermatology Day conference, Paris 2010].
    Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H1-11. PubMed ID: 21703464
    [No Abstract]   [Full Text] [Related]  

  • 17. Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma.
    Kim JS; Jeong YJ; Sohn MH; Lim ST; Kim DW; Jeong HJ; Kwak JY; Yim CY
    Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1995. PubMed ID: 20658231
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
    Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
    Belousova IE; Kazakov DV; Krivolapov IuA
    Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cDNA microarrays: revolutionary technology for the diagnosis, prognosis, and treatment of cutaneous T-cell lymphoma.
    Hinshaw MA; Wood GS
    Int J Dermatol; 2005 Mar; 44(3):181-3. PubMed ID: 15807722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.